Search Results 1021-1030 of 18457 for prednisone

  1. Ketorolac (ophthalmic route) - Side effects & dosage - Mayo Clinic

    Ketorolac eye drops is used to treat itching caused by seasonal allergic conjunctivitis (an allergy that occurs at only certain times of the year). It is also ...

  2. Furosemide (oral route) - Side effects & dosage - Mayo Clinic

    Furosemide is given to help treat fluid retention (edema) and swelling that is caused by congestive heart failure, liver disease, kidney disease, or other ...

  3. Elevate CLL R/R: Study of Acalabrutinib (ACP-196) Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia - Mayo Clinic

    ... prednisone daily or equivalent). Prior exposure to ibrutinib or to a B-cell receptor (BCR) inhibitor (e.g., Bruton tyrosine kinase [Btk] inhibitors or ...

  4. A Study of the Combination of IMCgp100 with Durvalumab and/or Tremelimumab for Patients with Advanced Cutaneous Melanoma - Mayo Clinic

    ... prednisone ≤ 10 mg QD or the equivalent, and must be no history of adrenal crisis; Local steroid therapies (eg, otic, ophthalmic, intra-articular or inhaled ...

  5. St. John's wort - Mayo Clinic

    John's wort, also called Hypericum perforatum, is a flowering shrub native to Europe. St. John's wort gets its name because it often blooms on the birthday of ...

  6. A Study Comparing Anitocabtagene Autoleucel To Standard Of Care Therapy In Participants With Relapsed/ Refractory Multiple Myeloma (IMMagine-3) - Mayo Clinic

    High-dose (eg, cumulative > 70 mg prednisone or equivalent) systemic steroid therapy or any other form of immunosuppressive therapy within 14 days before ...

  7. An Open-Label Extension of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis - Mayo Clinic

    Treatment with corticosteroids at a dose that exceeds the prednisone equivalent of 40 mg per day;; Treatment with immunosuppressive agents (e.g. ...

  8. Early Identification of Pulmonary Coccidioidomycosis - Mayo Clinic

    ... prednisone 5 milligrams daily, calcineurin inhibitors (tacrolimus, etc.), mycophenolate mofetil, rapamycin, others. Eligibility last updated 10/5/21 ...

  9. A Study of the Safety and Effectiveness of HBI-8000 with Nivolumab to Treat Melanoma, Renal Cell Carcinoma and Non-Small Cell Lung Cancer - Mayo Clinic

    Subjects with a condition requiring systemic treatment with either corticosteroids (> 10 mg daily prednisone equivalents) or other immunosuppressive medications ...

  10. PRGN-3006 Adoptive Cellular Therapy for CD33-Positive Relapsed or Refractory AML, MRD Positive AML or Higher Risk MDS - Mayo Clinic

    - Active autoimmune disease requiring systemic immunosuppressive therapy (i.e. >10mg of prednisone daily or equivalent). - Participant, who in the opinion ...